PAG
CCXI

Private Advisor Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Private Advisor Group’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$58K – 3733
2020
Q2 		$58K Buy
+1,000
New +$54.4K ﹤0.01% 2021

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Private Advisor Group's CCXI Position: Q3 2020 in Review

Private Advisor Group sold out of ChemoCentryx, Inc. (CCXI) in Q3 2020, closing a stake of 1,000 shares — an estimated $58K sold.

Private Advisor Group first reported a position in CCXI in Q2 2020 and held it in 1 quarter. The position peaked at $58K in Q2 2020. 204 funds tracked by Wall St. Rank hold CCXI as of Q3 2020.

  • Private Advisor Group reported no remaining ChemoCentryx, Inc. position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 1,000 ChemoCentryx, Inc. shares in Q3 2020, an estimated $58K.
  • Private Advisor Group first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's ChemoCentryx, Inc. position peaked at $58K in Q2 2020.
  • 204 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.